CARTO® 3 System and Real Time Intracardiac Ultrasound
NCT01716663 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 234
Last updated 2014-12-01
Summary
This is a prospective, multicenter, non-randomized observational study of subjects 18 years and older undergoing RF ablation with drug refractory recurrent symptomatic paroxysmal Atrial Fibrillation (AF).
Conditions
- Atrial Fibrillation
- Paroxysmal AF
Interventions
- DEVICE
-
Catheter Ablation
NAVISTAR® THERMOCOOL® SF Catheter with the CARTO® 3 System and the SOUNDSTAR® Ultrasound Catheter (with the CARTOSOUND® Software Module)
Sponsors & Collaborators
-
Biosense Webster, Inc.
lead INDUSTRY
Principal Investigators
-
Usman Siddiqui, MD · Osceola Regional Medical Center
-
Mathew Hutchinson, MD · University of Pennsylvania
-
Andy Tran, MD · Scottsdale Healthcare Research
-
Saumil Oza, MD · East Coast Institute for Research LLC, St. Vincent's Ambulatory Care, Inc.
-
Robert Fishel, MD · JFK Medical Center
-
Vijendra Swarup, MD · AZ Heart Rhythm Research Center
-
Mohit Rastogi, MD · Washington Adventist Hospital CCVR
-
Brett Gidney, MD · Santa Barbara Cottage Hospital
-
John Scherschel, MD · University of Nebraska
-
Dilip Mathew, MD · Pepin Heart Hospital
-
William Sauer, MD · University of Colorado, Denver
-
Marcie Berger, MD · Medical College of Wisconsin
-
Khawaja Baig, MD · Kettering Medical Center
-
Farhat Khairallah, MD · Tallahassee Research Institute
-
David Fitzgerald, MD · Scott & White Memorial Hospital
-
Gopi Dandamudi, MD · Geisinger Heart Institute
-
Ahmad Abdul-Karim, MD · Provena St. Joseph Medical Center
-
Douglas Esberg, MD · Main Line Health
-
Scott Burke, MD · St. Mary's Medical Center
-
Gregory Jones, MD · Wellmont CVA Heart Institute
-
Tapan Rami, MD · The Methodist Hospital Research Institute
-
Salem Sayar, MD · Northeast Georgia Heart Center, PC
-
Gunjan Shukla, MD · Hackensack Meridian Health
-
Philip Gentlesk, MD · Sentara Norfolk General Hospital
-
Asim Yunus, MD · Michigan CardioVascular Institute
-
Scott Reich, MD · Northeast Baptist Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- United States
Study Locations
More Related Trials
-
FIND CAN Trial: "CF-172"
NCT03033641 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study
NCT00449085 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation
NCT03729830 ·Status: COMPLETED
-
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
NCT07116525 ·Status: RECRUITING ·Phase: NA
-
AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation
NCT00785902 ·Status: WITHDRAWN ·Phase: PHASE3
-
Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
NCT01687166 ·Status: COMPLETED ·Phase: NA
-
CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
NCT03056222 ·Status: COMPLETED ·Phase: NA
-
A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter
NCT05373862 ·Status: COMPLETED ·Phase: NA
-
ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation
NCT02028143 ·Status: COMPLETED ·Phase: NA
-
Reduction of Fluoroscopy Exposure During Atrial Fibrillation Ablation
NCT02137798 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection
NCT04076917 ·Status: TERMINATED
-
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
NCT01385202 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Carto Versus Ensite 3D Electroanatomical Mapping Systems for Arrhythmias Ablations
NCT01651702 ·Status: WITHDRAWN ·Phase: NA
-
FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)
NCT00137540 ·Status: COMPLETED ·Phase: PHASE3
-
Personalized Atrial Fibrillation Ablation With QDOT
NCT04298177 ·Status: UNKNOWN ·Phase: PHASE4
-
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
NCT05883631 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation
NCT00560885 ·Status: COMPLETED ·Phase: PHASE3
-
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS
NCT01639495 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Operator-guided and Automatic Algorithm-guided Atrial Fibrillation Ablation
NCT02476227 ·Status: COMPLETED ·Phase: NA
-
Individualised Mapping in Persistent AF Ablation
NCT05065112 ·Status: UNKNOWN ·Phase: NA
-
Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients
NCT06801392 ·Status: RECRUITING
-
HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)
NCT01456000 ·Status: COMPLETED ·Phase: PHASE3
-
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
NCT00116428 ·Status: COMPLETED ·Phase: PHASE3
-
Hybrid Characterization of Driver Sites During Atrial Fibrillation and Sinus Rhythm
NCT05077670 ·Status: UNKNOWN
-
A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF
NCT06144632 ·Status: COMPLETED ·Phase: NA